LSTA Lisata Therapeutics, Inc.
$1.06▲ +3.92%
Healthcare
Other
Volume 75.4K
Avg Volume (10D) 59.0K
Key Metrics & Fundamentals
Market Cap
$11.45M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.96 - 5.07
% vs 50 MA
-24.17%
% vs 200 MA
-64.69%
RSI-14
40.5
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.75
Free Cash Flow
-$2.65M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.07M
COGS
–
Operating Exp
$3.99M
Operating Income
-$3.99M
EBIT
-$3.99M
Pretax Income
-$2.93M
Net Income
-$2.93M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Lisata adds biopharma finance veteran Jeffrey Farrow to board
Proactive · Oct 15, 2026 8:41 AM ET
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
GlobeNewswire · Oct 14, 2026 4:05 PM ET
Lisata Therapeutics wins new US patent for pancreatic cancer drug
Proactive · Oct 8, 2026 9:10 AM ET
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial
Proactive · Oct 5, 2026 9:43 AM ET
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
GlobeNewswire · Oct 5, 2026 8:00 AM ET
MARKETS LIVE: Nasdaq hits record high as tech stocks lead Wall Street higher
Proactive · Oct 5, 2026 7:03 AM ET
Lisata subsidiary Marea Therapeutics gets late-breaking slot at AHA Scientific Sessions
Proactive · Sep 24, 2026 8:55 AM ET
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
GlobeNewswire · Sep 24, 2026 8:00 AM ET
MARKETS LIVE: Wall Street ends mixed as Hormuz hopes ease Middle East jitters
Proactive · Sep 24, 2026 7:15 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See LSTA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.